Regen Health Physicians

Fibromyalgia in NYC: An Integrative and Regenerative Approach to Widespread Pain

RHPNY··4 min read
Fibromyalgia in NYC: Integrative & Regenerative Approach

Fibromyalgia affects approximately 4 million adults in the United States, the majority of them women. Despite being one of the most common chronic pain conditions, it remains widely misunderstood, frequently dismissed, and inadequately treated within conventional healthcare. At Regen Health Physicians NYC, Dr. Ajit Dhaliwal approaches fibromyalgia as what it actually is: a central sensitization syndrome with multiple biological drivers that respond to a targeted, integrative approach.

What Is Fibromyalgia?

Fibromyalgia is characterized by:

  • Widespread musculoskeletal pain lasting more than 3 months
  • Fatigue that is disproportionate to activity level
  • Cognitive dysfunction ("fibro fog") — difficulty with concentration, memory, and word retrieval
  • Sleep disturbance — non-restorative sleep despite adequate duration
  • Heightened sensory sensitivity — to pain, light, noise, and temperature

The 2010 American College of Rheumatology diagnostic criteria eliminated the need for tender point examination, instead using the Widespread Pain Index (WPI) and Symptom Severity Scale (SSS) — a shift that acknowledges the systemic, multi-domain nature of the condition.

The Central Sensitization Model

The most important advance in understanding fibromyalgia is the recognition that it represents central sensitization — a pathological amplification of pain signaling in the central nervous system. In fibromyalgia:

  • The spinal dorsal horn becomes hypersensitive, amplifying nociceptive signals
  • Descending inhibitory pathways from the brain (which normally suppress pain) are dysfunctional
  • NMDA receptors (involved in pain "wind-up") are hyperactivated
  • Brain imaging consistently shows altered activity in pain-processing regions

This explains why fibromyalgia pain is real, severe, and not "all in the head" — while simultaneously explaining why peripheral tissue damage (detectable by imaging) is typically absent.

Contributing Factors at RHPNY's Assessment

Rather than treating fibromyalgia as a uniform diagnosis, Dr. Dhaliwal investigates individual contributing factors:

Hormonal Contributors

Low testosterone, estrogen withdrawal (common in perimenopause), and hypothyroidism all lower pain thresholds. A comprehensive hormone panel often reveals addressable deficiencies. Hormone optimization can meaningfully reduce the central sensitization burden.

Sleep Architecture Dysfunction

Non-restorative sleep — specifically, disruption of delta (slow-wave) sleep — perpetuates fibromyalgia. The relationship is bidirectional: pain disrupts sleep, and sleep disruption lowers pain thresholds. Treatment must address both.

Gut Microbiome Dysbiosis

Emerging research links gut dysbiosis to central sensitization via the gut-brain axis. Increased intestinal permeability ("leaky gut") allows lipopolysaccharides (LPS) to enter circulation, driving systemic neuroinflammation. Many fibromyalgia patients have co-existing IBS, SIBO, or food intolerances.

Mitochondrial Dysfunction

Studies have documented reduced mitochondrial density and function in muscle biopsies from fibromyalgia patients — potentially explaining the characteristic fatigue and muscle pain. This is an area where peptide therapies such as SS-31 (elamipretide) and NAD+ precursors may have a role.

Psychological and Neurological Trauma

Adverse childhood experiences (ACEs) and trauma history are significantly more prevalent in fibromyalgia populations, consistent with the central sensitization model. Addressing the neurological imprint of trauma — through appropriate modalities — is part of a comprehensive approach.

The RHPNY Integrative Approach

Targeted Hormone Optimization

Addressing deficiencies in testosterone, thyroid, or estrogen — when present — often produces significant improvements in pain intensity, energy, and cognitive clarity. This is a first-line evaluation at RHPNY.

Peptide Therapy

Several peptides have evidence or strong mechanistic rationale in fibromyalgia:

  • BPC-157: systemic anti-inflammatory, gut healing, potential central analgesic effects
  • Selank: modulates the anxiety-pain interface, improves sleep architecture
  • Low-dose naltrexone (LDN): not a peptide, but frequently used alongside peptide protocols — reduces microglial activation and systemic neuroinflammation

Regenerative Approaches to Complicating Musculoskeletal Issues

Many fibromyalgia patients have co-existing tendinopathy, joint degeneration, or muscle trigger points. PRP injections targeting specific pain generators can reduce the peripheral input that maintains central sensitization — even if fibromyalgia itself is a central phenomenon.

Sleep Restoration

Strategies including low-dose melatonin, targeted supplementation (magnesium glycinate, low-dose doxepin), and addressing sleep apnea when present are central to reducing fibromyalgia severity.

Exercise as Medicine

Graded aerobic exercise — particularly low-impact Zone 2 training — remains the most evidence-supported intervention for fibromyalgia. It reduces central sensitization by downregulating NMDA receptor activity and improving descending inhibitory tone. Dr. Dhaliwal helps patients build a realistic, progressive exercise program that doesn't trigger post-exertional malaise.

What Progress Looks Like

Fibromyalgia does not resolve overnight. Most patients on a comprehensive RHPNY protocol experience:

  • Meaningful pain reduction (VAS score improvements of 30–50%) within 3–6 months
  • Significant sleep improvements within 4–8 weeks
  • Gradual clearing of cognitive fog over several months
  • Improved energy and functional capacity with sustained effort

The goal is not eliminating fibromyalgia as a label but reducing its impact on daily life to a level that allows patients to engage fully in work, relationships, and activities.

If you are managing fibromyalgia in NYC and have not found adequate relief with conventional treatment, book a consultation at RHPNY to explore a more comprehensive, personalized approach.

---

Medical Disclaimer: Fibromyalgia management should be supervised by a qualified physician. The strategies described here are not a substitute for conventional medical care. Individual results vary.